Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

BACKGROUND: Patients with renal impairment receiving classical anticoagulation for venous thromboembolism (VTE) are at increased risk of bleeding and possibly pulmonary embolism. We examined the efficacy and safety of oral rivaroxaban in patients with VTE with and without renal impairment. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thromb J
Main Authors: Bauersachs, Rupert M, Lensing, Anthonie WA, Prins, Martin H, Kubitza, Dagmar, Pap, Ákos F, Decousus, Hervé, Beyer-Westendorf, Jan, Prandoni, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Original Basic Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351845/
https://ncbi.nlm.nih.gov/pubmed/25750589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-12-25
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados